ArticleBMC medical research methodology2025
A partially heterogeneous weighted fusion learning method for potential heterogeneous treatment effect in multi-site survival study.
Article in BMC medical research methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundIn multi-site studies in clinical practice, the treatment effects may exhibit potential heterogeneity across different sites. Additionally, propensity score methods used to adjust for confounding may suffer from model misspecification, which can lead to biased estimates. Addressing both the potential heterogeneity of site-specific treatment effects and the issues of model misspecification in the context of multi-site survival data is a critical area that warrants further research.
methodsWe propose a novel partially heterogeneous weighted fusion learning method. This approach is designed to simultaneously identify and estimate potential heterogeneous treatment effects across sites, while also improving robustness against model misspecification in the estimation of survival causal effects across different sites. We evaluate the performance of this method through simulation studies and apply it to the real-world data from the Surveillance, Epidemiology, and End Result (SEER) database to assess whether the survival effect of surgery with adjuvant radiation therapy for breast cancer patients differs across sites in a multi-site study.
resultsSimulation studies demonstrate that our proposed method accurately identifies the potential heterogeneous treatment effects, and when the candidate models include the correct model, our method performs comparably to methods based on correctly specified propensity score models in estimating the site-specific hazard ratios. The application of our method to the SEER database revealed two distinct survival effects of surgery with adjuvant radiation therapy for breast cancer patients across sites. However, compared to our method, traditional methods that pool all sites together failed to identify this heterogeneity, while analyzing each site individually led to a reduction in statistical power.
conclusionThis study introduces a partially heterogeneous weighted fusion learning method for survival data that effectively identifies potential inter-site heterogeneity in treatment effects, while simultaneously addressing the issue of model misspecification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.